nab-Paclitaxel (Abraxane®): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors

被引：0
|
作者：
J Iglesias
机构：
[1] Abraxis Bioscience,
来源：
Breast Cancer Research | / 11卷
关键词：
Paclitaxel; Docetaxel; Metastatic Breast Cancer; Taxanes; Polysorbate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Radiation-guided drug delivery of nanoparticle albumin-bound paclitaxel to lung cancer
    Hariri, G.
    Han, Z.
    Hallahan, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S705 - S706
  • [42] Neoadjuvant therapy with nanoparticle albumin-bound (nab)-paclitaxel to enhance the resectability of locally advanced pancreatic cancer (LAPC)
    Cooray, Prasad
    Dean, Andrew Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] A phase I study of the mTOR inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel (nab-P)
    Abu-Khalaf, M. M.
    Gettinger, S. N.
    Trieu, V. N.
    Deshpande, H. A.
    DiGiovanna, M.
    Azodi, M.
    Desai, N.
    Kelly, W. K.
    Schwartz, P. E.
    Harris, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
    Shen, Xiaokang
    Chen, TianMing
    Liu, Nianlong
    Yang, Bo
    Feng, GuoDong
    Yu, Pengcheng
    Zhan, Chuanfei
    Yin, Na
    Wang, YuHuang
    Huang, Bin
    Chen, Shilin
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [45] Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
    Green, M. R.
    Manikhas, G. M.
    Orlov, S.
    Afanasyev, B.
    Makhson, A. M.
    Bhar, P.
    Hawkins, M. J.
    ANNALS OF ONCOLOGY, 2006, 17 (08) : 1263 - 1268
  • [46] Tailored neoadjuvant epirubicin and cyclophosphamide (EC) and nanoparticle albumin-bound paclitaxel (nab-P) in breast cancer.
    Khasraw, Mustafa
    Mukaro, Violet Rudo
    West, Linda
    White, Karen
    Rippy, Elisabeth
    Brandt, Conrad
    Tobler, Robert
    Murphy, Caitlin Clare
    Collins, Ian M.
    Baron-Hay, Sally E.
    Ashley, David M.
    Patil, Sujata
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [47] Minimal activity of nanoparticle albumin-bound (nab) paclitaxel in relapsed or refractory lymphomas: results of a phase-I study
    Goyal, Sagun
    Oak, Eunhye
    Luo, Jingqin
    Cashen, Amanda F.
    Carson, Kenneth
    Fehniger, Todd
    DiPersio, John
    Bartlett, Nancy L.
    Wagner-Johnston, Nina D.
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 357 - 362
  • [48] Combined modality treatment with ABI-007, nanoparticle albumin-bound (nab) paclitaxel:: modification of radiation response in vivo
    Wiedenmann, N.
    Valdecanas, D.
    Hunter, N.
    Farrar, D.
    Milas, L.
    Mason, K.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 97 - 97
  • [49] Outcomes and Costs of Nanoparticle Albumin-Bound(nab-) Paclitaxel Compared to Docetaxel in Women with Pretreated Metastatic Breast Cancer
    Donatti, Christina M.
    McLeod, Euan
    Lloyd, Adam
    Prunieras, Francois J.
    QUALITY OF LIFE RESEARCH, 2010, 19 : 113 - 113
  • [50] Systemic nanoparticle albumin-bound paclitaxel (nab-paclitaxel) for the prevention of in-stent restenosis (SNAPIST-II):: A randomized comparison of single dose and single dose plus repeat dose at 2 months
    McDonald, John E.
    Klinke, Peter
    Fung, Anthony
    Ricci, Donald
    Suciu, Ciprian
    Ortan, Florin
    Ursu, Mihai
    Mut-Vitcu, Bogdan
    Dima, Cristian
    Benedek, Imre
    Hintea, Theodora
    Capalneanu, Radu
    Mot, Stefan
    Dorobantu, Maria
    Balanescu, Serban
    Niculescu, Rodica
    Margolis, Jim
    Waksman, Ron
    Clawson, Alicia
    Rush, Selena
    Desai, Neil
    Hilton, David
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 224M - 224M
12345